• Non ci sono risultati.

Liu, Xiao-Rong; Xu, Dan; Liu, Bao Mini-Reviews in Medicinal Chemistry (2008), 8(10), 1053-1063.

N/A
N/A
Protected

Academic year: 2021

Condividi "Liu, Xiao-Rong; Xu, Dan; Liu, Bao Mini-Reviews in Medicinal Chemistry (2008), 8(10), 1053-1063. "

Copied!
4
0
0

Testo completo

(1)

93

BIBLIOGRAFIA

1) Masahiko Nishiyama, Hidetaka Educhi (Theme Editors), Advanced Drug Delivery Reviews 61 (2009) 367–368

2) Cao, Xin; You, Qi-Dong; Li, Zhi-Yu; Wang, Xiao-Jian; Lu, Xiao-Yun;

Liu, Xiao-Rong; Xu, Dan; Liu, Bao Mini-Reviews in Medicinal Chemistry (2008), 8(10), 1053-1063.

3) Thomas, S.M.; Brugge, J.S., Ann. Rev. Cell. Dev. Biol., 1997, 13, 513.

4) Biscardi, J.S.; Tice, D.A.; Parsons, S. J. Adv. Cancer Res., 1999, 76, 61.

5) Susa M.; Missbach, M.; Green, J. Trends Pharm. Sci., 2000, 21, 489.

6) Susa M.; Teti, A. Drug News Perspect., 2000, 13, 169.

7) Groundwater, P.W.,Solomons, K. R., Drewe, J.A.; Munawater, M.A.

Prog. Med. Chem., 1996, 33,233.

8) Parang, K.; Sun, G.Q. Expert Opin. Ther. Patents, 2005, 15, 1183 9) Kim. J.;Shin-ya, K.; Furihata, K.; Hayakawa, Y.; Seto, H. J. Org.

Chem.,1999, 64, 153

10) Puder, C.; Wagner, K.; Veltermann, R.; Hauptmann, R.; Potterat, O.

J.Nat. Prod., 2005, 68, 323

11) Fry, D. W.;Kraker, A.J.;McMichael, A., Ambroso, L.A.; Nelson, J.M.;

Leopold, W.R.; Connors, R.W.; Bridges, A. J. Science, 1994, 265, 1093 12) Allan Wissner, Dan M. Berger, Diane H. Boschelli, M. Brawner Floyd, Jr., Lee M. Greenberger, Brian C. Gruber, Bernard D. Johnson, Nellie Mamuya, Ramaswamy Nilakantan, Marvin F. Reich, Ru Shen, Hwei-Ru Tsou, Erik Upeslacis, Yu Fen Wang, Biqi Wu, Fei Ye, and Nan Zhang, J. Med. Chem., 2000, 43 (17), pp 3244–3256.

13) Schroeder, M.C.; Hamby, J.M.; Connolly, C.J.C.; Grohar, P.J.; Winters, R.T.: Baria, M.R.; Moore, C.W.; Boshelle, S.L.; Crean, S.M.;

Kraker,A.J.; Driscoll, D.L.; Vincent, P.W.; Elliot, W.L.; Lu, G.H.; Batley, B.L. J. Med. Chem. 2001,44, 1915.

14) Noronha, G.; Barrett, K.; Cao, J.G.; Dneprovskaia, E.; Fine, R.; Gong, X.C.; Gritzen, C.; Hood, J.; Kang, X.S.; Klebansky, B.; Li. G.; Liao, W.;

Lohse, D.; Mak, C.C.; Moorthy, S.S. Palanki; Pathak, V.P.; Renick, J.;

Soll, R., Splittgerber, U.; Wrasidlo, W.; Zeng, B.Q.; Zhao, N.N.; Zhon, Y.

Bioorg. Med. Chem. Lett., 2006, 16, 5546

15) Noronha, G.; Barrett, K.; Boccia, A.; Brodhag, T.; Cao, J.G.; Chow, C.P.; Dneprovskaia, F.; Doukas, J.; Fine, R.; Gong, X.C.; Critzen, C.;

Gu, H.; Hanna, E.; Hood, J.D.; Hu, S.; Kang, X.S.; Key, J.; Klebansky,

B.; Kousba, A.; Li, G.; Lohse, D.; Mak, C.C.; McPherson, A.; Palanki,

(2)

94

M.S.S.; Pathak, V.P.; Renick, J.; Shi, F.; Soll, R.; Splittgerber, U.;

Stoughton, S.; Tang, S.; Yee, S.Y.; Zeng, B.Q.; Zhao, N.N.; Zhu, H.

Bioorg. Med. Chem. Lett., 2007, 17, 602

16) Carraro, F.; Pucci, A.; Naldini, A.; Schenone, S.; Bruno, O.; Ranise, A.; Bondavalli, F.; Brullo, C.; Fossa, P.; Menozzi, G.; Mosti, L.;

Manetti, F.; Bolta, M. J. Med. Chem., 2004, 47, 1595

17) Carraro, F.; Pucci, A.; Naldini, A.; Schenone, S.; Bruno, O.; Ranise, A.; Bondavalli, F.; Brullo, C.; Fossa, P.; Menozzi, G.; Mosti, L.;

Manetti, F.; Bolta, M. J. Med. Chem., 2006, 49, 1549

18) Mohammadi, M.; McMahon, G.; Sun, L.; Tang, C.; Hirth, P.; Yeh. B.K.;

Hubbard, S.R.; Schlessinger, J. Science, 1997, 276,955

19) Sun, L.; Tran, N.; Liang, C.; Hubbard, S.; Tang, F.; Lipson, K.;

Schreck, R.; Zhou, Y.; McMahon, G.; Tamg, G. J. Med. Chem., 2000, 43, 2655

20) Kumar, A.; Ye, G.F.; Wang, Y.H.; Sun, G.Q.; Parang, K. J. Med.

Chem., 2006, 49, 3395

21) Vineron, A.; Robinson, J.B.; Gamelin, E.; Coqueret, O. Cancer Res., 2005, 65, 8927

22) Marchal, Juan A.; Nunez, Maria C.; Aranega, Antonia; Gallo, Miguel A.; Espinosa, Antonio; Campos, Joaquin M. Current Medicinal Chemistry, 2009, 16, 1166-1183

23) Balzarini J, Pannecouque C, Naesens L, Andrei G, Snoeck R, De Clercq E, Hocková D, Holý A. Nucleosides Nucleotides Nucleic Acids.

2004 Oct;23(8-9):1321-7.

24) Meier C., De Clercq E., Balzarini J., Eur. J Org Chem. 1998, 837-846.

25) Saniger, E.; Campos, J.M.; Entrena, A.; Marchal, J.A.; Suàrez, I.;

Arànega, A.; Choquesillo, D.; Niclòs, J.; Gallo, M.A.; Espinosa, A.;

Medium benzene-fused oxacycles with the 5-fluorouracil moiety:

synthesis, antiproliferative activities and apoptosis induction in breast cancer cells. Tetrahedron, 2003, 59, 5457-5467.

26) Li Huang and Chin Ho Chen Current Medicinal Chemistry, 2009, 16, 931-939.

27) Grune T. Biogerontology, 2000, 1: 31-40.

28) Schwartz A. L., Ciechanover A. Ann. Rev. Med., 1999, 50: 57-74.

29) Kane RC, Bross PF, Farrell AT, Pazdur R, Oncologist. 2003;8(6):508- 13.

30) P Bonvini, E Zorzi, G Basso and A Rosolen, Leukemia 21, 838-842 (April 2007)

31) Peter M. Voorhees, E. Claire Dees, Bert O’Neil, and Robert Z.

Orlowski (2003), Clin Cancer Res 9 (17): 6316-25.

(3)

95

32) Kisselev AF, Callard A, Goldberg AL., J. Biol. Chem. 2006 Mar 31;281(13):8582-90.

33) Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ. Blood. 2007 Nov 1;110(9):3281-90.

34) Ho YK, Bargagna-Mohan P, Wehenkel M, Mohan R, Kim KB., LMP2- specific inhibitors: chemical genetic tools for proteasome biology.

Chem Biol. 2007 Apr;14(4):419-30.

35) Gao, Y; Lecker, S; Post, M.J.; Hietaranta, A.J.; Li, J.; Volk, R.; Li, M.;

Sato, K.; Saluta, A.K.; Steer, M.L.; Goldberg, A.L.; Simons, M. J. Clin.

Invest., 2000, 106, 439-48.

36) Kristin R. Landis-Piwowar, Sheng Biao Wan, Richard A. Wiegand, Deborah J. Kuhn, Tak Hang Chan, and Q. Ping Dou J Cell Physiol.

2007 Oct;213(1):252-60.

37) Lövborg H, Oberg F, Rickardson L, Gullbo J, Nygren P, Larsson R. Int J Cancer. 2006 Mar 15;118(6):1577-80.

38) Huang L, Ho P, Chen CH. FEBS Lett. 2007, 581(25):4955-9.

39) Y. Kashiwada, F. Hashimoto, L.M. Cosentino, C.H. Chen, P.E. Garrett and K.H. Lee, J. Med. Chem. 39 (1996), pp. 1016–1017.

40) Zhou J, Yuan X, Dismuke D, Forshey BM, Lundquist C, Lee KH, Aiken C, Chen CH., J Virol. 2004 Jan;78(2):922-9.

41) Holz-Smith SL, Sun IC, Jin L, Matthews TJ, Lee KH, Chen CH., Antimicrob Agents Chemother. 2001 Jan;45(1):60-6.

42) Mayaux JF, Bousseau A, Pauwels R, Huet T, Hénin Y, Dereu N, Evers M, Soler F, Poujade C, De Clercq E, et al., Proc Natl Acad Sci U S A.

1994 Apr 26;91(9):3564-8.

43) Soler F, Poujade C, Evers M, Carry JC, Hénin Y, Bousseau A, Huet T, Pauwels R, De Clercq E, Mayaux JF, Le Pecq JB, Dereu N., J Med Chem. 1996 Mar 1;39(5):1069-83.

44) Huang L, Yuan X, Aiken C, Chen CH., Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action ., Antimicrob Agents Chemother. 2004 Feb;48(2):663-5.

45) Wu P, Liu T, Hu Y. Curr. Med. Chem. 2009;16(8):916-30.

46) Vivanco I and Sawyers CL. “The posphatidylinositol 3-kinase-Akt pathway in human cancer”. Nature Cancer Rev 2002; 2:489-501.

47) Martelli AM, Nyakern M, et all.. “Phosphoinositide 3-kinase/Akt

signalling pathway and its therapeutical implications for human acute

myeloid leukaemia”. Leukemia 2006; 20:911-928.

(4)

96

48) Cully M, You H, et all.. “Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis”. Nature Reviews Cancer 2006; 6:184-192.

49) Chuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, Yardena Samuels, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Sandra B. Gabelli, L. Mario Amzel, Science,. 2007, 318, 1744-17488.

50) Bader AG, Kang S, Zhao L, Vogt PK. Nat Rev Cancer, 2005, 5(12):921-9.

51) Holleran, J. L.; Fourcade, J.; Egorin, M. J.; Eiseman, J. L.; Parise, R.

A.; Musser, S. M.; White, K. D.; Covey, J. M.; Forrest, G. L.; Pan, S.-S.

Drug Metab. Dispos., 2004, 32, 490-496.

52) Ihle, T. N.; Williams, R.; Chow, S.; Chew, W.; Berggren, I. M.; Paine- Murrieta, G.; Minion, D. J.; Halter, J. R.; Wipf, P.; Abraham, R.;

Kirkpatrick, L.; Powis, G. Mol. Cancer Ther., 2004, 3, 763-772.

53) Jackson, S. P.; Schoenwaelder, S. M.; Goncalves, I.; Nesbitt, W. S.;

Yap, C. L.; Wright, C. E.; Kenche, V.; Anderson, K. E.; Dopheide, S.

M.; Yuan, Y.; Sturgeon, S. A.; Prabaharan, H.; Thompson, P. E.;

Smith, G. D.; Shepherd, P. R.; Daniele, N.; Kulkarni, S.; Abbott, B.;

Saylik, D.; Jones, C.; Lu, L.; Giuliano, S.; Hughan, S. C.; Angus, J. A.;

Robertson, A. D.; Salem, H. H. Nat. Med., 2005, 11, 507-514.

54) Pomel, V.; Klicic, J.; Covini, D.; Church, D. D.; Shaw, J. P.;Roulin, K.;

Burgat-Charvillon, F.; Valognes, D.; Camps, M.; Chabert, C.; Gillieron, C.; Francon, B.; Perrin, D.; Leroy, D.; Gretener, D.; Nichols, A.; Vitte, P. A.; Carboni, S.; Rommel, C.; Schwarz, M. K.; Ruckle, T. J. Med.

Chem., 2006, 49, 3857-3871.

Riferimenti

Documenti correlati

Tlavelogues, .iournals, diaries, and tourist guides on Cuba proliferated, testi$ring to the charm the island exerted on North Americans, whether for its exotic landscapes and

In many ways, The Video Game Debate: Unravel- ling the Physical, Social, and Psychological Effects of Digital Games presents a rebut- tal to the rising moral panic surrounding

Small waterfalls can be set up in suitable areas to create the artistic conception of small rivers and streams, which can not only meet the visual needs of

The impact of molecular imaging on clinical medicine has been extensive since it allows a physician to diagnose a patient’s illness, prescribe treatment, and

[r]

[r]

verifica sulla struttura dei controsoffitti della Piscina Bianchi tale relazione dovrà contenere: a) gli elementi atti a determinare le circostanze di somma

The present results allow to conclude that: i) It is possible to obtain a highly active catalyst with Ru loading of the order of 3.5 wt%, with a significant dropping of the catalyst